<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="other" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Our Dermatol Online</journal-id>
<journal-title>Our Dermatol Online</journal-title>
<issn pub-type="epub">2081-9390</issn>
<publisher>
<publisher-name>Our Dermatology Online</publisher-name>
<publisher-loc>Poland</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">OURD-10-300</article-id>
<article-id pub-id-type="doi">10.7241/ourd.20193.22</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Clinical Image</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Sclerema neonatorum in a premature newborn</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Younes</surname>
<given-names>Barbach</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
<xref ref-type="corresp" rid="cor1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mohammed</surname>
<given-names>Chaouche</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Abdellah</surname>
<given-names>Dah Cherif</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sara</surname>
<given-names>Elloudi</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hanane</surname>
<given-names>Baybay</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zahra</surname>
<given-names>Mernissi Fatima</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
</contrib>
</contrib-group>
<aff id="aff1"><italic>Departement of Dermatology, CHU Hassan II, F&#x00E8;s, Morocco</italic></aff>
<author-notes>
<corresp id="cor1">
<bold>Corresponding author:</bold> Dr. Barbach Younes, E-mail: <email xlink:href="dr.younes2011@gmail.com">dr.younes2011@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<year>2019</year>
</pub-date>
<volume>10</volume>
<issue>3</issue>
<fpage>300</fpage>
<lpage>301</lpage>
<history>
<date date-type="received"><day>23</day><month>09</month><year>2018</year></date>
<date date-type="accepted"><day>03</day><month>12</month><year>2018</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x000a9; Our Dermatol Online 3</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
</license>
</permissions>
</article-meta>
</front>
<body>
<sec id="sec1-1">
<title/>
<p>Sclerema of the newborn is classified among the lobular panniculitis, it is an extremely rare affection, most often lethal which occurs on a weak ground or sepsis [<xref ref-type="bibr" rid="ref1">1</xref>]. The sclerema was announced for the first time at the beginning of the XVIIth century and the most authors have confused it with the scleroedema and cytosteatonecrosis of the newborn so the most diverse names have been given to these three conditions combined. Several theories have been proposed to explain his pathogenesis, which remains poorly understood [<xref ref-type="bibr" rid="ref2">2</xref>]. The diagnosis of sclerema is clinical, it is manifested in newborns during their first week of life by a generalized cutaneous induration which gradually achieves, within a few days, a diffuse sclerous skin condition very paradoxically respecting the hands and feet, but may extend to compromising life-threatening dietary and respiratory functions. Sclerema treatment is based on newborn conditioning, antibiotic therapy, systemic corticosteroids, exsanguino-transfusion and currently the advent of intravenous immunoglobulins. Despite these treatments, the prognosis of sclerema remains reserved with a high rate of mortality [<xref ref-type="bibr" rid="ref3">3</xref>].</p>
<p>We report the case of a premature infant on D10 of life, hospitalized in neonatology for acute respiratory distress, which had since birth an induration of the diffuse skin. Dermatological examination showed the presence of a generalized sclerosis taking the whole body respecting the genitals as well as the palmo-plantar region [Figs. <xref ref-type="fig" rid="F1">1</xref>-<xref ref-type="fig" rid="F2 F3">3</xref>], the diagnosis of newborn sclerema was retained after eliminating other diagnoses including neonatal cytosteotonecrosis and scleroderma, and then was put on cortico antibiotic combination.</p>
<fig id="F1">
<label>Figure 1</label>
<caption>
<p>Diffuse back sclerosis.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-10-300-g001.tif"/>
</fig>
<fig id="F2">
<label>Figure 2</label>
<caption>
<p>Generalized sclerosis.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-10-300-g002.tif"/>
</fig>
<fig id="F3">
<label>Figure 3</label>
<caption>
<p>Sclerosis respecting palmar region.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-10-300-g003.tif"/>
</fig>
<sec id="sec2-1">
<title>Consent</title>
<p>The examination of the patient was conducted according to the Declaration of Helsinki principles.</p>
</sec>
</sec>
</body>
<back>
<ref-list>
<title>REFERENCES</title>
<ref id="ref1">
<label>1</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S-C</given-names>
</name>
</person-group>
<article-title>Sclerema neonatorum in a full-term infant showing favorable prognosis</article-title>
<source>Ann Dermatol</source>
<year>2017</year>
<volume>29</volume>
<fpage>790</fpage>
<lpage>3</lpage>
</nlm-citation>
</ref>
<ref id="ref2">
<label>2</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shrestha</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chaudhary</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Koirala</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Sclerema neonatorum treated successfully with parenteral steroids: an experience from a resource poor country</article-title>
<source>Case Rep Pediatr</source>
<year>2017</year>
<volume>2017</volume>
<fpage>1</fpage>
<lpage>2</lpage>
</nlm-citation>
</ref>
<ref id="ref3">
<label>3</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeb</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Darmstadt</surname>
<given-names>GL</given-names>
</name>
</person-group>
<article-title>Sclerema neonatorum: a review of nomenclature, clinical presentation, histological features, differential diagnoses and management</article-title>
<source>J Perinatol Off J Calif Perinat Assoc</source>
<year>2008</year>
<volume>28</volume>
<fpage>453</fpage>
<lpage>60</lpage>
</nlm-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="supported-by">
<p><bold>Source of Support:</bold> Nil</p>
</fn>
<fn fn-type="conflict">
<p><bold>Conflict of Interest:</bold> None declared.</p>
</fn>
</fn-group>
</back>
</article>
